Biotechnology Portfolio Biotechnology Fund Technical Analysis

FBIOX Fund  USD 20.42  0.21  1.02%   
As of the 26th of November, Biotechnology Portfolio shows the Risk Adjusted Performance of (0.02), standard deviation of 1.26, and Mean Deviation of 0.9012. Biotechnology Portfolio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.

Biotechnology Portfolio Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biotechnology, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Biotechnology
  
Biotechnology Portfolio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Biotechnology Portfolio technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.
A focus of Biotechnology Portfolio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biotechnology Portfolio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Biotechnology Portfolio Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biotechnology Portfolio volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Biotechnology Portfolio Trend Analysis

Use this graph to draw trend lines for Biotechnology Portfolio Biotechnology. You can use it to identify possible trend reversals for Biotechnology Portfolio as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Biotechnology Portfolio price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Biotechnology Portfolio Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Biotechnology Portfolio Biotechnology applied against its price change over selected period. The best fit line has a slop of   0.007  , which may suggest that Biotechnology Portfolio Biotechnology market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.84, which is the sum of squared deviations for the predicted Biotechnology Portfolio price change compared to its average price change.

About Biotechnology Portfolio Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biotechnology Portfolio Biotechnology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on its technical analysis. In general, a bottom-up approach, as applied to this mutual fund, focuses on Biotechnology Portfolio price pattern first instead of the macroeconomic environment surrounding Biotechnology Portfolio. By analyzing Biotechnology Portfolio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biotechnology Portfolio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biotechnology Portfolio specific price patterns or momentum indicators. Please read more on our technical analysis page.

Biotechnology Portfolio November 26, 2024 Technical Indicators

Most technical analysis of Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biotechnology from various momentum indicators to cycle indicators. When you analyze Biotechnology charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Biotechnology Portfolio One Year Return

Based on the recorded statements, Biotechnology Portfolio Biotechnology has an One Year Return of 37.3919%. This is much higher than that of the Fidelity Investments family and significantly higher than that of the Health category. The one year return for all United States funds is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios